Biotech Advancements in Hearing Loss Treatments

Sensorion, a biotechnology company specializing in hearing loss disorders, is attending the 42nd Annual J.P. Morgan Healthcare Meeting in San Francisco and participating in the Jefferies London Healthcare Conference and McDermott Will Emery’s Life Sciences Symposium. Two companies, Akouos and Decibel Therapeutics, have launched clinical trials to restore hearing in children with OTOF gene mutations. Regeneron Pharmaceuticals has announced its acquisition of Decibel Therapeutics, strengthening its gene therapy programs for hearing loss.